Résultats de la recherche - Lars Bergmann

  • Résultat(s) 1 - 1 résultats de 1
Affiner les résultats
  1. 1
    Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals

    Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals par Yi Rang Han, Anna Jeong, Kanwal Ayub, Shelly V. Gupta, Lars Bergmann, Drew S. Kern, Fernando Pagan, Matthew Rosebraugh

    Publié 2025-01-01

    Background: Foslevodopa/foscarbidopa (LDp/CDp) are soluble prodrugs of levodopa/carbidopa delivered as a continuous subcutaneous infusion (CSCI) via a portable pump to provide continuous levodopa exposures. Objective: To assess the safety of LDp/CDp and the relative bioavailability of levodopa/carbi...

    Description complète

    Accéder au texte intégral
    Article

    Ajouter aux favoris
    Enregistré dans:

Outils de recherche: